BSX vs HLIO · P/E 20, rev $10.65B vs P/E 47, rev $460.3M
Boston Scientific Corp (BSX) versus Helios Technologies Inc (HLIO) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Helios Technologies Inc (HLIO) is a specialty industrial machinery company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported HLIO revenue for 2026-07-04 was $460.3M. Net income was $41.6M. HLIO currently screens at market cap $2.84B and trailing P/E 47.2.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. HLIO currently screens at market cap $2.84B and trailing P/E 47.2.
Not investment advice. Open the BSX and HLIO stock pages for the full models.
Not investment advice.